Company Filing History:
1 out of 48 
1 out of 376 
1 out of 1,297 
Years Active: 1994-1995
Title: Michihiko Sugimoto: Innovator in Nasal Administration Technologies
Introduction
Michihiko Sugimoto is a notable inventor based in Numazu, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of emulsion preparations for nasal administration. With a total of 2 patents, Sugimoto's work focuses on enhancing the efficacy and safety of drug delivery systems.
Latest Patents
Sugimoto's latest patents include a parathyroid hormone-containing emulsion for nasal administration and a calcitonin-containing emulsion for nasal administration. The latter invention aims to provide emulsion preparations that allow for safe and effective administration of calcitonins, surpassing the limitations of conventional preparations. These emulsions utilize a calcitonin as the active ingredient, combined with an azacycloalkane derivative as an absorption promoter, such as 1-[2-(decylthio)ethyl] azacyclopentan-2-one, along with glycyrrhizic acid or its salt.
Career Highlights
Throughout his career, Sugimoto has worked with reputable companies, including Toyo Jozo Company, Ltd. and Hisamitsu Pharmaceutical Company, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Sugimoto has collaborated with notable colleagues, including Nakayuki Yamamoto and Hideo Sakakibara. These partnerships have likely enriched his research and development efforts in the field of nasal drug delivery systems.
Conclusion
Michihiko Sugimoto's contributions to nasal administration technologies highlight his innovative spirit and dedication to improving pharmaceutical formulations. His patents reflect a commitment to advancing drug delivery methods, ensuring safer and more effective treatments for patients.